NCT06491056 Prospective Asian Multicenter Prostate Cancer Focal Therapy Study (ProAMFocal)
| NCT ID | NCT06491056 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Singapore General Hospital |
| Condition | Prostate Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2023-05-06 |
| Primary Completion | 2028-05-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2023-05-06 with a primary completion date of 2028-05-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a multicenter observational study of patients undergoing focal therapy for prostate cancer in Asia
Eligibility Criteria
Inclusion Criteria: * Prostate Adenocarcinoma * Maximum Gleason score 4+4 * Maximum cancer volume 1.5 ml (up to 2 lesions) or 3 ml (single lesion) * Maximum Prostate Specific Antigen (PSA) level 15 ng/dl * Maximum clinical stage T2c * American Society of Anesthesiologist Criteria 2 or less Exclusion Criteria: * Extra-prostatic Extension on multi parametric magnetic resonance imaging (mpMRI); capsular contact is permitted
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06491056 clinical trial?
This trial is open to male participants only, aged 40 Years or older, up to 85 Years, studying Prostate Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06491056 currently recruiting?
Yes, NCT06491056 is actively recruiting participants. Contact the research team at tay.kae.jack@singhealth.com.sg for enrollment information.
Where is the NCT06491056 trial being conducted?
This trial is being conducted at Singapore, Singapore.
Who is sponsoring the NCT06491056 clinical trial?
NCT06491056 is sponsored by Singapore General Hospital. The trial plans to enroll 500 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.